Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
WithdrawnNCT02758067
What is this study about?Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.
This study was withdrawn before enrollment.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- H. Lundbeck A/S
TerminatedNCT00998608
Official study titleA Randomized, Double-Blind, Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Combined With Low Dose of Haloperidol in the Treatment of Schizophrenic Disorder
This study ended early.
In Kaohsiung CitySchizophreniaMedication studyAges 18–55
- Countries
- Taiwan
- Sponsor
- Kaohsiung Kai-Suan Psychiatric Hospital
CompletedNCT04040998
Official study titleCompensatory Cognitive Training for Psychosocial Correlates and Self-stigma in Persons With Schizophrenia
This study has finished and is no longer accepting participants.
In TaoyuanSchizophreniaBehavioural studyAges 20–65
- Countries
- Taiwan
- Sponsor
- Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
CompletedNCT01055509
Official study titleEffectiveness of Cognitive Adaptation Training Applied to Cognitive Impairment in Schizophrenia - A Randomised Trial
This study has finished and is no longer accepting participants.
Multiple locations, including AabenraaSchizophreniaBehavioural studyAges 18–70
- Countries
- Denmark
- Sponsor
- University of Southern Denmark
CompletedNCT01598220
Official study titleEfficacy Study of a Computer Cognitive Remediation Program in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In TerrassaSchizophreniaBehavioural studyAges 18–55
- Countries
- Spain
- Sponsor
- Gemma Garrido García
TerminatedNCT00508560
Official study titleContingency Management for Smoking Cessation Among Veterans With Schizophrenia or Other Psychoses
This study ended early.
In SeattleSchizophrenia, AddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
TerminatedNCT00184509
Official study titleContinued Early Intervention for Recent-onset Schizophrenia. A Randomized Controlled Study.
This study ended early.
In TrondheimSchizophreniaBehavioural studyAges 18–35
- Countries
- Norway
- Sponsor
- Norwegian University of Science and Technology
CompletedNCT03019887
Official study titleCorrelation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction in Patients Undergoing High-dose Antipsychotic Therapy
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20–70
- Countries
- Sponsor
- Juntendo University
CompletedNCT00140192
Official study titleCreatine as a New Treatment for Schizophrenia:A Double-Blind Trial
This study has finished and is no longer accepting participants.
In BeershevaSchizophreniaMedication studyAges 18–60
- Countries
- Israel
- Sponsor
- Beersheva Mental Health Center
CompletedNCT03317769
Official study titleCreating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaInterventional studyAges 18–60
- Countries
- United States
- Sponsor
- Posit Science Corporation
CompletedNCT00231933
About this title
Culturally Responsive Person-Centered Care for Psychosis
Read the official source — NCT00231933What is this study about?This study assessed quality of life.
This study has finished and is no longer accepting participants.
In New HavenSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT02298985
Official study titleCurcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study
This study has finished and is no longer accepting participants.
Multiple locations, including BeershevaSchizophreniaMedication studyAges 18–60
- Countries
- Israel
- Sponsor
- Beersheva Mental Health Center